BIOMAT Database Logo BIOMAT Database Logo

[Liver changes during treatment with antitubercular agents]. 1975

D Velojic, and Z Jankovic, and B MArsenic

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

D Velojic, and Z Jankovic, and B MArsenic
[Liver damage of allergic origin during treatment with antitubercular agents].
June 1968, Casopis lekaru ceskych,
D Velojic, and Z Jankovic, and B MArsenic
[Treatment with secondary antitubercular agents].
May 1968, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
D Velojic, and Z Jankovic, and B MArsenic
[Treatment with new antitubercular agents].
November 1968, Deutsche medizinische Wochenschrift (1946),
D Velojic, and Z Jankovic, and B MArsenic
[Response to hepatic dysfunction during treatment using antitubercular agents].
February 2007, Kekkaku : [Tuberculosis],
D Velojic, and Z Jankovic, and B MArsenic
[Treatment with antitubercular agents after kidney transplantation].
October 1991, Bratislavske lekarske listy,
D Velojic, and Z Jankovic, and B MArsenic
[Immunological changes during the treatment of chronic liver diseases with immunosuppressive agents].
January 1976, Acta medica Iugoslavica,
D Velojic, and Z Jankovic, and B MArsenic
[Toxicity of antitubercular agents for the liver].
January 1973, Deutsche medizinische Wochenschrift (1946),
D Velojic, and Z Jankovic, and B MArsenic
[Antitubercular agents. 49. Thiohydrazides, potential antitubercular agents].
February 1990, Die Pharmazie,
D Velojic, and Z Jankovic, and B MArsenic
[Antitubercular agents in the treatment of tuberculosis. II. Antitubercular agents of the 2d series].
January 1962, Farmaceuticky obzor,
D Velojic, and Z Jankovic, and B MArsenic
[Q & A: peritonitis resistant to treatment with antitubercular agents].
July 2010, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
Copied contents to your clipboard!